Activation of interferon regulatory factor 3 by replication-competent vaccinia viruses improves antitumor efficacy mediated by T cell responses.

Riederer, Stephanie; Fux, Robert; Lehmann, Michael H; Volz, Asisa; Sutter, Gerd; Rojas, Juan J

Activation of interferon regulatory factor 3 by replication-competent vaccinia viruses improves antitumor efficacy mediated by T cell responses.

Riederer, Stephanie; Fux, Robert; Lehmann, Michael H; Volz, Asisa; Sutter, Gerd; Rojas, Juan J.

Affiliation

Riederer S; Division of Virology, Department of Veterinary Sciences, LMU Munich, 80539 Munich, Germany.
Fux R; Division of Virology, Department of Veterinary Sciences, LMU Munich, 80539 Munich, Germany.
Lehmann MH; Division of Virology, Department of Veterinary Sciences, LMU Munich, 80539 Munich, Germany.
Volz A; Division of Virology, Department of Veterinary Sciences, LMU Munich, 80539 Munich, Germany.
Sutter G; German Center for Infection Research (DZIF), Partner Site Munich, 80539 Munich, Germany.
Rojas JJ; Division of Virology, Department of Veterinary Sciences, LMU Munich, 80539 Munich, Germany.

Mol Ther Oncolytics ; 22: 399-409, 2021 Sep 24.

Article de En | MEDLINE | ID: mdl-34553028

Mots clés

cancer virotherapy; immunmodulation; immunotherapy; poxvirus; vaccina virus replication

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Mol Ther Oncolytics Année: 2021 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google